Business & Tech
Ameridose Closure Extended Six Weeks
The Westborough firm shares owners with the Framingham company tied to the meningitis outbreak.
State health officials have extended the closing of Ameridose for six weeks, the Boston Globe reports.
The Globe reports the state Department of Public Health said in a statement that the Westborough drug company will continue undergoing a joint state and federal investigation regarding “unsanitary conditions and questionable sterility practices at the facility."
Ameridose shares owners with the New England Compounding Center, a specialty pharmacy in Framingham linked to the national deadly meningitis outbreak.
Interested in local real estate?Subscribe to Patch's new newsletter to be the first to know about open houses, new listings and more.
In November, federal Food and Drug Administration inspectors reported seeing insects and a bird while inspecting Ameridose.
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.
We’ve removed the ability to reply as we work to make improvements. Learn more here
